These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8726405)

  • 1. Biological characteristics of CD7(+) acute leukemia.
    Miwa H; Nakase K; Kita K
    Leuk Lymphoma; 1996 Apr; 21(3-4):239-44. PubMed ID: 8726405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
    Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
    Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
    Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
    Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
    Kita K; Miwa H; Nakase K; Kawakami K; Kobayashi T; Shirakawa S; Tanaka I; Ohta C; Tsutani H; Oguma S
    Blood; 1993 May; 81(9):2399-405. PubMed ID: 7683218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characteristics of CD7 positive acute myelogenous leukaemia.
    Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
    Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thrombopoietin on acute myelogenous leukemia blasts.
    Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine GM-CSF transcription in the leukemic progenitor cell line KG1a is mediated by the transcription factor ETS1 and is negatively regulated through SECTM1 mediated ligation of CD7.
    Bade-Döding C; Göttmann W; Baigger A; Farren M; Lee KP; Blasczyk R; Huyton T
    Biochim Biophys Acta; 2014 Mar; 1840(3):1004-13. PubMed ID: 24211252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotype of acute leukemia and its clinical significance].
    Zhu H; Niu T; Meng W; Xu C; Lei S
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human granulocyte colony-stimulating factor receptors in acute myelogenous leukemia.
    Kondo S; Okamura S; Asano Y; Harada M; Niho Y
    Eur J Haematol; 1991 Apr; 46(4):223-30. PubMed ID: 1707827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of CD7 and CD56 antigens in acute leukaemias.
    Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
    Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular and biological characterization of CD7-positive acute leukemia cells--an investigation of the established cell line, HSM911].
    Iwasaki H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):750-66. PubMed ID: 7525434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and clinical significance of CD7 expression in acute myeloid leukemia.
    Saxena A; Sheridan DP; Card RT; McPeek AM; Mewdell CC; Skinnider LF
    Am J Hematol; 1998 Aug; 58(4):278-84. PubMed ID: 9692390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on prognosis of acute leukemia subtypes Ly + AML and My + ALL].
    Liu B; Li R; Wu HJ; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):421-4. PubMed ID: 17493361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia.
    Kita K; Nishii K; Ohishi K; Morita N; Takakura N; Kawakami K; Miwa H; Shirakawa S
    Leukemia; 1993 Aug; 7(8):1184-90. PubMed ID: 7688838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
    Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
    Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
    Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
    J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.